DeNovaMed Competitors and Similar CompaniesClear all

DeNovaMed's competitors and similar companies include Kangstem Biotech, Corestem and Triumvira.

	DeNovaMed DeNovaMed is a pharmaceutical company specializing in therapeutic approaches to combat bacterial infections.	Kangstem Biotech Kangstem Biotech (강스템바이오텍) is a biopharmaceutical company that focuses on blood-derived stem cell therapy.	Corestem Corestem (코아스템) is a biopharmaceutical company that researches and commercializes stem cell technology.	Triumvira Triumvira Immunologics is an immunotherapy company.
Founding Date	Founding Date 2006	Founding Date 2010	Founding Date 2003	Founding Date 2015
Type	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Healthcare biotech drug development life sciences pharma therapy
Locations	Locations Halifax, CA HQ Toronto, CA	Locations KR HQ	Locations Seongnam-si, KR HQ	Locations Austin, US HQ Hamilton, CA
Employees	Employees 6	Employees 97	Employees 354	Employees 287% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₩7.7b (FY, 2024)	Revenue (est.) ₩28.8b (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₩838.6m (FY, 2024)	Cost of goods ₩25.6b (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₩7.1b (FY, 2024)	Gross profit ₩5.6b (FY, 2024)	Gross profit N/A
Net income	Net income N/A	Net income (₩7.1b) (FY, 2024)	Net income (₩26.3b) (FY, 2024)	Net income N/A
Funding
Latest funding round	Latest funding round $ 500k (about 14 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 55m (almost 6 years ago)